"Adding sex and gender to today’s studies not only benefit women’s health, it is also key to improving men’s health."...
We are truly witnessing a transformation in healthcare as new technologies enable the generation of new data and insights at an unprecedented scale....
"We need to make cell therapy affordable and scalable…It’s not sustainable… the failure rate is too high…it’s too labor intensive and it’s too slow!" -Ira Mellman, PhD, Vice President, Cancer Immunology, Genentech, PMWC Jan. 26-28, 2022 Silicon Valley Track 1, Day 2 Chair...
Without a doubt, COVID-19 has changed the view of how the world should approach pathogen surveillance, detection, and containment....
Molecular profiling applications in clinical oncology are evolving faster than ever relying on advances in technology and allowing clinicians to identify the molecular and genetic signatures that help deliver treatments that are highly specific to a given tumor type....
"Newborn screening is a public health initiative. The goal is to look for disease where early identification makes a difference in the outcome as compared to identifying it symptomatically later in life."- Dr. Jerry Vockley...
Centered on revolutionary science, the story of mRNA technology as a new class of drug is packed with passion and brilliance....
I wanted to share a quote from Dr. Julie Johnson, PharmD, Dean and Distinguished Professor of Pharmacy, College of Pharmacy, University of Florida and honoree at PMWC 2021 Pittsburgh...
We are excited to host the 20th Precision Medicine World Conference (PMWC) in Pittsburgh on September 23-24, 2021....
Data is the most important asset when it comes to making informed treatment decisions, to accelerate or optimize therapeutic development, and to reduce cost in the healthcare system by administering therapeutics in a targeted and optimized way....
